{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T04:02:04Z","timestamp":1785124924546,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03345-z","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:20:23Z","timestamp":1783945223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced anti-tumor effects of Imatinib and immune checkpoint inhibitors on gastrointestinal stromal tumor cells (GISTs): insights from monoculture and 3D co-culture models"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5848-7905","authenticated-orcid":false,"given":"Panagiotis","family":"Sarantis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Vallilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7560-0575","authenticated-orcid":false,"given":"Ioanna A.","family":"Anastasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0080-9032","authenticated-orcid":false,"given":"Eleni-Myrto","family":"Trifylli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0583-0540","authenticated-orcid":false,"given":"Evangelos","family":"Koustas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8801-7015","authenticated-orcid":false,"given":"John","family":"Griniatsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1369-8201","authenticated-orcid":false,"given":"Michalis V.","family":"Karamouzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5803-4527","authenticated-orcid":false,"given":"Athanasios G.","family":"Papavassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"3345_CR1","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1016\/j.ejca.2011.08.008","volume":"47","author":"G Gatta","year":"2011","unstructured":"Gatta G, Van Der Zwan JM, Casali PG, et al. Rare Cancers Are Not So Rare: The Rare Cancer Burden in Europe. Eur J Cancer. 2011;47:2493\u2013511. https:\/\/doi.org\/10.1016\/j.ejca.2011.08.008.","journal-title":"Eur J Cancer"},{"key":"3345_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3390\/ijms22020493","volume":"22","author":"C Vallilas","year":"2021","unstructured":"Vallilas C, Sarantis P, Kyriazoglou A, et al. Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules. Int J Mol Sci. 2021;22:493. https:\/\/doi.org\/10.3390\/ijms22020493.","journal-title":"Int J Mol Sci"},{"key":"3345_CR3","doi-asserted-by":"publisher","unstructured":"Corless CL. Gastrointestinal Stromal Tumors: What Do We Know Now? Mod Pathol. 2014;27 Suppl 1:S1-16. https:\/\/doi.org\/10.1038\/modpathol.2013.173","DOI":"10.1038\/modpathol.2013.173"},{"key":"3345_CR4","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/pharmaceutics17070923","volume":"17","author":"XH Xiao","year":"2025","unstructured":"Xiao XH, Zhang QS, Hu JY, et al. Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor After Imatinib Resistance. Pharmaceutics. 2025;17:923. https:\/\/doi.org\/10.3390\/pharmaceutics17070923.","journal-title":"Pharmaceutics"},{"key":"3345_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1758834012450935","volume":"4","author":"D Kee","year":"2012","unstructured":"Kee D, Zalcberg JR. Current and Emerging Strategies for the Management of Imatinib-Refractory Advanced Gastrointestinal Stromal Tumors. Ther Adv Med Oncol. 2012;4:255\u201370. https:\/\/doi.org\/10.1177\/1758834012450935.","journal-title":"Ther Adv Med Oncol"},{"key":"3345_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2174\/1567201820666221122120657","volume":"21","author":"C Huang","year":"2024","unstructured":"Huang C, Ma X, Wang M, Cao H. Drugs in the GIST Field (Therapeutic Targets and Clinical Trial Staging). Curr Drug Deliv. 2024;21:80\u201390. https:\/\/doi.org\/10.2174\/1567201820666221122120657.","journal-title":"Curr Drug Deliv"},{"key":"3345_CR7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.tips.2023.02.003","volume":"44","author":"V Jain","year":"2023","unstructured":"Jain V, Singh MP, Amaravadi RK. Recent Advances in Targeting Autophagy in Cancer. Trends Pharmacol Sci. 2023;44:290\u2013302. https:\/\/doi.org\/10.1016\/j.tips.2023.02.003.","journal-title":"Trends Pharmacol Sci"},{"key":"3345_CR8","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3390\/biom15070915","volume":"15","author":"H You","year":"2025","unstructured":"You H, Wang L, Meng H, Li J, et al. Autophagy: Shedding Light on the Mechanisms and Multifaceted Roles in Cancers. Biomolecules. 2025;15:915. https:\/\/doi.org\/10.3390\/biom15070915.","journal-title":"Biomolecules"},{"key":"3345_CR9","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3390\/life11121304","volume":"11","author":"E Koustas","year":"2021","unstructured":"Koustas E, Trifylli EM, Sarantis P, et al. The Implication of Autophagy in Gastric Cancer Progression. Life (Basel). 2021;11:1304. https:\/\/doi.org\/10.3390\/life11121304.","journal-title":"Life (Basel)"},{"key":"3345_CR10","doi-asserted-by":"publisher","first-page":"107327482513843","DOI":"10.1177\/10732748251384365","volume":"32","author":"J Shifa","year":"2025","unstructured":"Shifa J, Amin T, Fakruddin M, Rahman K, et al. Unveiling the Paradoxical Nature of Autophagy in Cancer Cell Fate. Cancer Control. 2025;32:10732748251384365. https:\/\/doi.org\/10.1177\/10732748251384365.","journal-title":"Cancer Control"},{"key":"3345_CR11","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.3390\/biomedicines10071596","volume":"10","author":"VAM Vitto","year":"2022","unstructured":"Vitto VAM, Bianchin S, Zolondick AA, et al. Molecular Mechanisms of Autophagy in Cancer Development, Progression, and Therapy. Biomedicines. 2022;10:1596. https:\/\/doi.org\/10.3390\/biomedicines10071596.","journal-title":"Biomedicines"},{"key":"3345_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev-cancerbio-041816-122338","volume":"1","author":"N Santana-Codina","year":"2017","unstructured":"Santana-Codina N, Mancias JD, Kimmelman AC. The Role of Autophagy in Cancer. Annu Rev Cancer Biol. 2017;1:19\u201339. https:\/\/doi.org\/10.1146\/annurev-cancerbio-041816-122338.","journal-title":"Annu Rev Cancer Biol"},{"key":"3345_CR13","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1158\/2159-8290.CD-19-0292","volume":"9","author":"RK Amaravadi","year":"2019","unstructured":"Amaravadi RK, Kimmelman AC, Debnath J. Targeting Autophagy in Cancer: Recent Advances and Future Directions. Cancer Discov. 2019;9:1167. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0292.","journal-title":"Cancer Discov"},{"key":"3345_CR14","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1016\/j.devcel.2022.10.008","volume":"57","author":"T Kataura","year":"2022","unstructured":"Kataura T, Sedlackova L, Otten EG, et al. Autophagy Promotes Cell Survival by Maintaining NAD Levels. Dev Cell. 2022;57:2584\u201398. https:\/\/doi.org\/10.1016\/j.devcel.2022.10.008. .e11.","journal-title":"Dev Cell"},{"key":"3345_CR15","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.3390\/ijms19113466","volume":"19","author":"CW Yun","year":"2018","unstructured":"Yun CW, Lee SH. The Roles of Autophagy in Cancer. Int J Mol Sci. 2018;19:3466. https:\/\/doi.org\/10.3390\/ijms19113466.","journal-title":"Int J Mol Sci"},{"key":"3345_CR16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ. A Guide to Cancer Immunotherapy: From T Cell Basic Science to Clinical Practice. Nat Rev Immunol. 2020;20:651\u201368. https:\/\/doi.org\/10.1038\/s41577-020-0306-5.","journal-title":"Nat Rev Immunol"},{"key":"3345_CR17","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3390\/biom10050666","volume":"10","author":"E Koustas","year":"2020","unstructured":"Koustas E, Sarantis P, Papavassiliou AG, Karamouzis MV. The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors. Biomolecules. 2020;10:666. https:\/\/doi.org\/10.3390\/biom10050666.","journal-title":"Biomolecules"},{"key":"3345_CR18","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.3390\/ijms23052847","volume":"23","author":"P Dobosz","year":"2022","unstructured":"Dobosz P, St\u0119pie\u0144 M, Golke A, Dzieci\u0105tkowski T. Challenges of the Immunotherapy: Perspectives and Limitations of the Immune Checkpoint Inhibitor Treatment. Int J Mol Sci. 2022;23:2847. https:\/\/doi.org\/10.3390\/ijms23052847.","journal-title":"Int J Mol Sci"},{"key":"3345_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/cancers18030344","volume":"18","author":"E Turlej","year":"2026","unstructured":"Turlej E, Domaradzka A, Koksharov R, Gizak A. Immune-Centered Cross-Talk Between Cancer Cells and the Tumor Microenvironment-Implications for Therapy. Cancers (Basel). 2026;18:344. https:\/\/doi.org\/10.3390\/cancers18030344.","journal-title":"Cancers (Basel)"},{"key":"3345_CR20","doi-asserted-by":"publisher","first-page":"e70569","DOI":"10.1002\/jbt.70569","volume":"39","author":"IA Anastasiou","year":"2025","unstructured":"Anastasiou IA, Tentolouris A, Sarantis P, Rebelos E, Eleftheriadou I, Tentolouris N. Chronic Bisphenol-A Exposure Enhances ROS and AGEs Production via the RAGE\/PI3K\/AKT\/MTOR Signaling Pathway, Inducing Apoptosis in Human Pancreatic \u03b2-Cells. J Biochem Mol Toxicol. 2025;39:e70569. https:\/\/doi.org\/10.1002\/jbt.70569.","journal-title":"J Biochem Mol Toxicol"},{"key":"3345_CR21","doi-asserted-by":"publisher","first-page":"513823","DOI":"10.3389\/fmolb.2020.00033","volume":"7","author":"C Jensen","year":"2020","unstructured":"Jensen C, Teng Y. Is It Time to Start Transitioning From 2D to 3D Cell Culture? Front Mol Biosci. 2020;7:513823. https:\/\/doi.org\/10.3389\/fmolb.2020.00033.","journal-title":"Front Mol Biosci"},{"key":"3345_CR22","doi-asserted-by":"publisher","unstructured":"Mu P, Zhou S, Lv T, Xia F, Shen L, Wan J, et al. Newly developed 3D in vitro models to study tumor-immune interaction. J Exp Clin Cancer Res. 2023;42. https:\/\/doi.org\/10.1186\/s13046-023-02653-w.","DOI":"10.1186\/s13046-023-02653-w"},{"key":"3345_CR23","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1056\/nejmoa020461","volume":"347","author":"GD Demetri","year":"2002","unstructured":"Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors. N Engl J Med. 2002;347:472\u201380. https:\/\/doi.org\/10.1056\/nejmoa020461.","journal-title":"N Engl J Med"},{"key":"3345_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4291\/wjgp.v13.i1.15","volume":"13","author":"Y Sugiyama","year":"2022","unstructured":"Sugiyama Y, Sasaki M, Kouyama M, Tazaki T, Takahashi S, Nakamitsu A. Current Treatment Strategies and Future Perspectives for Gastrointestinal Stromal Tumors. World J Gastrointest Pathophysiol. 2022;13:15\u201333. https:\/\/doi.org\/10.4291\/wjgp.v13.i1.15.","journal-title":"World J Gastrointest Pathophysiol"},{"key":"3345_CR25","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/ars.2007.1957","volume":"10","author":"D Trachootham","year":"2008","unstructured":"Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P. Redox Regulation of Cell Survival. Antioxid Redox Signal. 2008;10:1343\u201374. https:\/\/doi.org\/10.1089\/ars.2007.1957.","journal-title":"Antioxid Redox Signal"},{"key":"3345_CR26","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.2174\/1381612825666190215121712","volume":"24","author":"JE Klaunig","year":"2018","unstructured":"Klaunig JE. Oxidative Stress and Cancer. Curr Pharm Des. 2018;24:4771\u20138. https:\/\/doi.org\/10.2174\/1381612825666190215121712.","journal-title":"Curr Pharm Des"},{"key":"3345_CR27","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.lungcan.2008.10.013","volume":"64","author":"M Prunotto","year":"2009","unstructured":"Prunotto M, Bosco M, Daniele L, et al. Imatinib Inhibits in Vitro Proliferation of Cells Derived from a Pleural Solitary Fibrous Tumor Expressing Platelet-Derived Growth Factor Receptor-Beta. Lung Cancer. 2009;64:244\u20136. https:\/\/doi.org\/10.1016\/j.lungcan.2008.10.013.","journal-title":"Lung Cancer"},{"key":"3345_CR28","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3389\/fphar.2020.01106","volume":"11","author":"J Bouitbir","year":"2020","unstructured":"Bouitbir J, Panajatovic MV, Frechard T, Roos NJ, Kr\u00e4henb\u00fchl S. Imatinib and Dasatinib Provoke Mitochondrial Dysfunction Leading to Oxidative Stress in C2C12 Myotubes and Human RD Cells. Front Pharmacol. 2020;11:1106. https:\/\/doi.org\/10.3389\/fphar.2020.01106.","journal-title":"Front Pharmacol"},{"key":"3345_CR29","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12957-020-01933-5","volume":"18","author":"J Chen","year":"2020","unstructured":"Chen J, Li S, Yao Q, et al. The Efficacy and Safety of Combined Immune Checkpoint Inhibitors (Nivolumab plus Ipilimumab): A Systematic Review and Meta-Analysis. World J Surg Oncol. 2020;18:150. https:\/\/doi.org\/10.1186\/s12957-020-01933-5.","journal-title":"World J Surg Oncol"},{"key":"3345_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1179\/102453311X12902908412039","volume":"16","author":"G Can","year":"2011","unstructured":"Can G, Ekiz HA, Baran Y. Imatinib Induces Autophagy through BECLIN-1 and ATG5 Genes in Chronic Myeloid Leukemia Cells. Hematology. 2011;16:95\u20139. https:\/\/doi.org\/10.1179\/102453311X12902908412039.","journal-title":"Hematology"},{"key":"3345_CR31","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.3390\/ijms27052183","volume":"27","author":"M Jalouli","year":"2026","unstructured":"Jalouli M, Harrath AH, Al-Zharani M, Rahman MA. Autophagy Modulation in Cancer Immunotherapy, Emerging Molecular Targets and Drug Selection Strategies. Int J Mol Sci. 2026;27:2183. https:\/\/doi.org\/10.3390\/ijms27052183.","journal-title":"Int J Mol Sci"},{"key":"3345_CR32","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.trecan.2021.05.003","volume":"7","author":"E White","year":"2021","unstructured":"White E, Lattime EC, Guo JY. Autophagy Regulates Stress Responses, Metabolism, and Anticancer Immunity. Trends Cancer. 2021;7:778\u201389. https:\/\/doi.org\/10.1016\/j.trecan.2021.05.003.","journal-title":"Trends Cancer"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03345-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03345-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03345-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T03:46:45Z","timestamp":1785124005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03345-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["3345"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03345-z","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"28 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Bioethics Committee of the National and Kapodistrian University of Athens Medical School (approval number: 341\/11.03.2021).","order":3,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"219"}}